Parmax Pharma fundamental analysis

PARMAX

34.7

0.91 (2.69%)
Last updated on 4 Dec, 2025 | 15:26 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Parmax Pharma Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

36.44

Sector P/B

0.91

Sec. Div. Yield

0.56

  • Parmax Pharma Fundamentals is currently trading with a P/E Ratio of 0, compared to the sector average of 36.44. Its P/B Ratio stands at 0, while the sector’s is 0.91. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.56%.

Parmax Pharma Score Card

  • Price

    Attractive

  • Growth

    Good

  • Quality

    Poor

  • Management

    Poor

  • On its scorecard, Parmax Pharma reflects: Price – Attractive, Growth – Good, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.